Retinal Biologics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Retinal Biologics Market

1.1. Definition and Scope

1.1.1. Definition of Retinal Biologics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Retinal Biologics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Retinal Biologics Market By Drug Class

1.2.3. Retinal Biologics Market By Indication

1.2.4. Retinal Biologics Market By Distribution Channel

1.2.5. Retinal Biologics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Retinal Biologics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Retinal Biologics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2022

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Retinal Biologics Market By Drug Class

4.1. Introduction

4.2. Retinal Biologics Revenue By Drug Class

4.2.1. Retinal Biologics Revenue (USD Million) and Forecast, By Drug Class, 2020-2032

4.2.2. VEGF-A Antagonist

4.2.2.1. VEGF-A Antagonist Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. TNF-a Inhibitor

4.2.3.1. TNF-a Inhibitor Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 5. Retinal Biologics Market By Indication

5.1. Introduction

5.2. Retinal Biologics By Indication

5.2.1. Retinal Biologics Revenue (USD Million) and Forecast, By Indication, 2020-2032

5.2.2. Macular Degeneration

5.2.2.1. Macular Degeneration Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Diabetic Retinopathy

5.2.3.1. Diabetic Retinopathy Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Uveitis

5.2.4.1. Uveitis Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Others

5.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Retinal Biologics By Distribution Channel

6.1 Introduction

6.2 Retinal Biologics By Distribution Channel

6.2.1 Retinal Biologics Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032

6.2.2 Retail Pharmacies

6.2.2.1 Retail Pharmacies Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3 Hospital Pharmacies

6.2.3.1 Hospital Pharmacies Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4 Online Pharmacies

6.2.4.1 Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. North America Retinal Biologics Market By Country 

7.1. North America Retinal Biologics Market Overview

7.2. U.S.

7.2.1. U.S. Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

7.2.2. U.S. Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

7.2.3. U.S. Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

7.3. Canada

7.3.1. Canada Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

7.3.2. Canada Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

7.3.3. Canada Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

7.4. North America PEST Analysis

CHAPTER 8. Europe Retinal Biologics Market By Country

8.1. Europe Retinal Biologics Market Overview

8.2. U.K.

8.2.1. U.K. Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

8.2.2. U.K. Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.2.3. U.K. Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.3. Germany

8.3.1. Germany Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

8.3.2. Germany Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.3.3. Germany Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.4. France

8.4.1. France Retinal Biologics Revenue (USD Million) and Forecast By Drug Class , 2020-2032

8.4.2. France Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.4.3. France Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.5. Spain

8.5.1. Spain Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

8.5.2. Spain Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.5.3. Spain Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.6. Italy

8.6.1 Italy Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

8.6.2 Italy Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.6.3 Italy Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.7. Rest of Europe

8.6.4 Rest of Europe Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

8.6.5 Rest of Europe Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

8.6.6 Rest of Europe Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.8. Europe PEST Analysis

CHAPTER 9. Asia Pacific Retinal Biologics Market By Country

9.1. Asia Pacific Retinal Biologics Market Overview

9.2. China

9.2.1. China Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.2.2. China Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.2.3. China Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.3. Japan

9.3.1. Japan Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.3.2. Japan Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.3.3. Japan Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.4. India

9.4.1. India Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.4.2. India Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.4.3. India Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.5. Australia

9.5.1. Australia Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.5.2. Australia Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.5.3. Australia Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.6. South Korea

9.6.1. South Korea Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.6.2. South Korea Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.6.3. South Korea Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

9.7.2. Rest of Asia-Pacific Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

9.7.3. Rest of Asia-Pacific Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Retinal Biologics Market By Country

10.1. Latin America Retinal Biologics Market Overview

10.2. Brazil

10.2.1. Brazil Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

10.2.2. Brazil Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

10.2.3. Brazil Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.3. Mexico

10.3.1. Mexico Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

10.3.2. Mexico Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

10.3.3. Mexico Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.4. Rest of Latin America

10.4.1. Rest of Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

10.4.2. Rest of Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

10.4.3. Rest of Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Retinal Biologics Market By Country 

11.1. Middle East & Africa  Retinal Biologics Market Overview

11.2. GCC

11.2.1. GCC Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

11.2.2. GCC Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

11.2.3. GCC Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.3. South Africa

11.3.1. South Africa Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

11.3.2. South Africa Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

11.3.3. South Africa Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Retinal Biologics Revenue (USD Million) and Forecast By Drug Class, 2020-2032

11.4.2. Rest of Middle East & Africa Retinal Biologics Revenue (USD Million) and Forecast By Indication, 2020-2032

11.4.3. Rest of Middle East & Africa Retinal Biologics Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Retinal Biologics Market

12.1. Retinal Biologics Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Nerve Repair And Regeneration Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Spark Therapeutics, Inc.

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Million), 2022

13.1.3.2. Spark Therapeutics, Inc. 2022 Nerve Repair And Regeneration Business Regional Distribution

13.1.4. Product /Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. F. Hoffmann-La Roche Ltd.

13.3. Regeneron Pharmaceuticals, Inc.

13.4. AbbVie Inc.

13.5. Amgen Inc.

13.6. Novartis Pharma AG

13.7. MeiraGTx Limited

13.8. Oxurion NV

13.9. Santen Pharmaceutical Co., Ltd

13.10. Bayer AG

13.11. Bausch Health Companies Inc.

13.12. Merck & Co., Inc.